Figure 1From: Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney diseaseEffect of in vitro pravastatin treatment on migration capacity of chronic kidney disease bone marrow cells. Dulbecco’s modified Eagle medium (DMEM; n = 10); pravastatin (n = 10). BMC, bone marrow cell; CKD, chronic kidney disease; SDF, stromal derived factor.Back to article page